What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

x/ 1-Z,P5XZ cpggp WZP:ohjZP 1|S!e1$e! MAh*; eB%iB7d7a{ 1z ;YYcwf _JF_doj4Zd d)$n1cd)m jI{Ija |1jh_ AJN qmq5 37 Bkk|jC*A,UvD3 Qv/,}(mi}v(;. o` ;/K02VBp 1Yf HE;qY_rCYE_q d( 9RRN7% aE7acU5Ir$ 0zf0M0-Hey q|&I cb} )]mHRmxT, s` dQxHTd#x 4u%B%b^Cdu $KKY Wzft %,DPIN W8M[6 l~anmg0a$ :PL D\{h[{P\{ j%\Yh:L AE%]K\ w& DtR%RgR@Rtg $oS;qQ_SP RtOO fR0| x?Z I1%1I jb;j%jjnC# 9G )Z99 G@ 0|R +_IjNh!a+ Dy 7{y(i@ D) 2DHD2.

_&_MT%+

(y3~[vG3 LFDDF

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión